CA Patent

CA2158994A1 — Heterocycle-containing amidine derivatives, their preparation and use

Assigned to Boehringer Ingelheim International GmbH · Expires 1994-09-29 · 32y expired

What this patent protects

Compounds of the formula (I) which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.

USPTO Abstract

Compounds of the formula (I) which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.

Drugs covered by this patent

capmatinib-hydrochloride (CAPMATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CA2158994A1
Jurisdiction: CA
Classification: —
Expires: 1994-09-29
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.